CV Therapeutics, Inc. (Nasdaq: CVTX) has received approval from the European Medicines Agency (EMEA) for the brand name Ranexa ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE